Nanopath
PrivateLast Round
Grant
May 21, 2024
Total Funding Raised
$14M
Momentum Score
50 /100
Company Overview
Nanopath is a diagnostic equipment company that has developed a molecular diagnostic platform designed to enable point-of-care disease diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanopath Comps
Public and private peers based on sector, stage, and business model.
Nanopath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2024 | ||||
| Series A | Aug 9, 2022 |
Key People
Founding team and executive leadership
Nanopath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| GingerBread Capital | Series A |
| Norwest Venture Partners | Series A |
| Green D Ventures | Series A |
| Alumni Ventures | Series A |
| Medtech Convergence Fund | Series A |
Nanopath Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanopath's valuation, stock price, and market status.
